What Happened?
Shares of medical device company CooperCompanies (NASDAQ: COO) fell 13.9% in the afternoon session after the company reported weak second-quarter results impacted by channel inventory destocking and decided to retain its CooperSurgical business.
According to a company press release and earnings commentary, CooperCompanies reported second-quarter revenue of $1.07 billion, remaining flat year-over-year and missing analyst estimates of $1.10 billion. While organic revenue grew just 1%—also falling short of expectations—profitability demonstrated some resilience, with operating margins expanding to 20.8% from 16.6% a year ago, which allowed adjusted earnings of $1.15 per share to edge past the $1.12 consensus. Chief Executive Officer Al White noted that proactive U.S. channel inventory reductions at CooperVision weighed heavily on top-line performance and will continue to be a drag into the next quarter. Consequently, management lowered its full-year revenue guidance to a midpoint of $4.24 billion (down from $4.30 billion) and dropped its full-year adjusted EPS outlook to $4.53 at the midpoint.
In addition to the operational headwinds, CooperCompanies concluded a strategic review initiated in December 2025, with its board unanimously deciding to retain the CooperSurgical business after assessing acquisition proposals. The board cited valuation disconnects linked to incoming non-hormonal IUD competition and recent litigation settlements. To help cushion the impact, the company expanded its share repurchase authorization to $3 billion. Following the report, William Blair downgraded CooperCompanies to Market Perform from Outperform, highlighting the revenue pressure from channel destocking and the unexpected decision not to divest the CooperSurgical unit.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy CooperCompanies? Access our full analysis report here, it’s free.
What Is The Market Telling Us
CooperCompanies’s shares are not very volatile and have only had 4 moves greater than 5% over the last year. Moves this big are rare for CooperCompanies and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 9 months ago when the stock gained 7.6% on the news that the company reported third-quarter 2025 results that beat profit expectations and provided an upbeat earnings forecast for the upcoming fiscal year. For the quarter, revenue grew 4.6% year-over-year to $1.07 billion, meeting Wall Street's estimates, while adjusted earnings per share of $1.15 came in 3.2% ahead of consensus. The company's organic revenue, which filters out currency changes and acquisitions, also rose 3%, slightly better than anticipated. Looking ahead, investors were encouraged by the company's guidance for fiscal year 2026, which projects adjusted earnings per share of $4.53 at the midpoint, beating analyst expectations by 3.1%. The outlook suggested confidence in sustained profitability, outweighing a slight year-over-year contraction in quarterly operating margin.
CooperCompanies is down 32.4% since the beginning of the year, and at $54.81 per share, it is trading 35% below its 52-week high of $84.32 from January 2026. Investors who bought $1,000 worth of CooperCompanies’s shares 5 years ago would now be looking at only $485.77.
ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.
Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.
